scholarly journals Osteonecrosis of Femoral Head Treated with Extracorporeal Shock Wave Therapy: Analysis of Short-term Clinical Outcomes of Treatment with Radiologic Staging

Hip & Pelvis ◽  
2015 ◽  
Vol 27 (4) ◽  
pp. 250 ◽  
Author(s):  
Jin-Young Lee ◽  
Jae-Woo Kwon ◽  
Jung-Seob Park ◽  
Kyeol Han ◽  
Woo-jin Shin ◽  
...  
2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Abdulrahman D. Algarni ◽  
Hassan M. Al Moallem

Objective. Femoral head osteonecrosis is a progressive clinical condition with significant morbidity and long-term disability. Several treatment modalities including both surgical and nonsurgical options have been used with variable levels of success. High-energy extracorporeal shock wave therapy is a nonoperative treatment option that has been described for early-stage disease. We aimed to assess the functional and radiological outcomes of extracorporeal shockwave therapy (ESWT) in the treatment of osteonecrosis of the femoral head (ONFH). Methods. Thirty-three hips of 21 patients were included in this study. Adult patients with ONFH of any etiology and in the precollapse stage were included. Clinical (visual analogue scale [VAS] and Harris hip score [HHS]) and radiological (plain radiographs and magnetic resonance imaging [MRI]) evaluations were performed before and after intervention. We used 3000–4500 pulses in a single session performed under general anesthesia. Results. At an average of 8 months after ESWT, pain scores and HHS were significantly improved compared with the preintervention scores (p<0.001). The overall clinical outcomes were improved in 21 hips (63.3%), unchanged in 5 hips (15.15%), and worsened in 7 hips (21.2%). A trend toward a decrease in the size of the ONFH was observed although not of clinical significance (p=0.235). MRI revealed significant resolution of bone marrow edema (p<0.003). Regression was observed in 9 lesions (42.9%) and progression in 1 lesion (4.7%); no change was observed in the remaining 23 lesions (52.4%). Conclusion. ESWT is a viable noninvasive treatment option for early-stage ONFH. It significantly improves clinical outcomes and may halt or delay the radiographic progression of the disease in the precollapse stage.


Author(s):  
P. Lizis

<p><strong>Background.</strong> The surgical removal of heel spur (HS) provokes many controversial opinions, but clinical studies show the risk of complication after operation. An alternative to the surgical removal of HS is Extracorporeal Shock Wave Therapy (ESWT), because it is non-invasive method.<br /><strong>Objective.</strong> The aim of the study is to compare the short-term analgesic effects of ESWT and conservative treatment (CT) in males with chronic HS.<br /><strong>Methods.</strong> Sixty patients (mean age 54.9±4.3 years; range 42 to 59 years) were examined who had pain associated with HS. In the shockwave group (group 1) patients received 1000–2000 impulses of shocks to the affected heel in a single session. The patients in this group took a series of 5 ESWT in 1 week intervals. Patients in the control group (group 2) at the same time received CT consisting of nonsteroidal anti-inflammatory drugs (NSAIDs), orthotics and a local cortisone injection. The basic method of research was to evaluate pain according to Visual Analogue Scale (VAS) 0–10. The patients of the two groups were tested before the treatment, after the last treatment and 3 months and 6 months after the treatment.<br /><strong>Results.</strong> A significant decrease of VAS (p=0.000) was seen in the shockwave group. In the control group no significant decrease of VAS was seen.<br /><strong>Conclusions.</strong> ESWT reduces pain more effectively than CT in men with chronic HS.</p><p><br /><strong>KEY WORDS:</strong> extracorporeal shock wave therapy, conservative treatment, visual analogue scale, heel spur, pain.</p>


Medicine ◽  
2020 ◽  
Vol 99 (31) ◽  
pp. e21300
Author(s):  
Qing-hui Ji ◽  
Shi-chen Liu ◽  
Jie Miao ◽  
Zhi-xin Ren ◽  
Yu-fei Yuan ◽  
...  

Pain Medicine ◽  
2019 ◽  
Vol 20 (9) ◽  
pp. 1745-1749 ◽  
Author(s):  
Tannaz Ahadi ◽  
Maryam Esmaeili Jamkarani ◽  
Gholam Reza Raissi ◽  
Korosh Mansoori ◽  
Seyede Zahra Emami Razavi ◽  
...  

Abstract Objective The aim of this study was to compare the efficacy of prolotherapy with hypertonic dextrose and radial shock wave therapy in chronic lateral epicondilosis. Design Prospective single-blind randomized clinical trial. Setting Physical medicine and rehabilitation clinic. Subjects Thirty-three patients with at least three months of signs and symptoms of lateral epicondilosis, as well as failure of at least one of the conservative treatments, randomly allocated into two groups. Methods Sixteen patients received three sessions of shock wave therapy, and 17 received one session prolotherapy. Severity of pain via visual analog scale (VAS), grip strength via Baseline Pneumatic Dynamometer, pressure pain threshold (PPT) by algometer and Disabilities of Arm, Shoulder, and Hand quick questionnaire (Quick DASH) were assessed at baseline, four weeks, and eight weeks after the intervention. Results Within-group analysis showed that in both groups, differences between all of the outcome measures were significant after four and also eight weeks. Between-group analysis after four and eight weeks showed that the VAS and Quick DASH had significantly more improvement in the shock wave group. However, the two groups were similar regarding grip strength and PPT. No complication was observed in the two groups. Conclusions Based on the results of this study, a regiment of three sessions (weekly) of radial extracorporeal shock wave therapy is significantly more effective than one session of prolotherapy with 20% dextrose regarding pain and function in the management of chronic lateral epicondylosis in short-term follow-up.


Sign in / Sign up

Export Citation Format

Share Document